Peter Frampton, the British guitarist known for his influence in rock music, has been coping with a progressive muscle disease while continuing to make music. The condition, inclusion body myositis (IBM), was diagnosed in 2014 after several years of symptoms, including muscle weakness and falls.

Frampton first noticed something was wrong in 2009 during a hiking trip in Big Sur, California, with his son Julian, also a musician. At the time, Frampton was 59 years old and found his legs felt unusually weak and unsteady, describing the sensation as if “there were insects” vibrating in his muscles. This loss of strength marked the beginning of a gradual decline caused by IBM, a disease characterized by the gradual replacement of muscle tissue with fat, primarily affecting the limbs and leading to increasing physical impairment.

Despite the diagnosis and the challenges that followed, Frampton has remained active in the music scene. Recognizing the limited time he might have to play guitar at his previous level, he released three albums in five years that featured a mix of cover songs and reworked versions of his earlier hits. More recently, he has collaborated with his son Julian on new material, adapting his playing techniques to accommodate his weakening arms.

Frampton has spoken candidly about his condition and outlook, emphasizing acceptance as a coping strategy. “Big things never worried me, because the big things you can’t do anything about,” he said. “If I don’t accept what I have, I’m going to be mad for the rest of my life.” He expressed a renewed sense of satisfaction with his music and life, stating, “In my mind, I’m more successful than I’ve ever been. Because I like myself, I like what I do. I’ve reached the point where I don’t care what anybody else thinks.”

At 76 years old, Frampton continues to find ways to navigate the physical challenges imposed by IBM while pursuing his passion for music. His determination illustrates a commitment to his art and an ability to adapt to significant personal adversity.